Vor Biopharma boosts leadership team

Stem cell-focused oncology company Vor Biopharma made a series of appointments to its leadership team.

Advertisement

The company named Sadik Kassim, PhD, its chief technology officer, and hematological and gene engineering research specialist Tirtha Chakraborty, PhD, joined as vice president of research.

The appointments follow Vor’s recent move to a new headquarters in Cambridge, Mass., and the recent appointment of Dr. Robert Ang as the company’s new CEO and president.

More articles on biologics:
Dr. Raymond Gardocki: Endoscopic spine surgery in the US — will it catch up to other countries?  
Clarifying patient, provider goals before surgery and robotics in spine: Q&A with Dr. Kris Radcliff
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.